You are here

Home » Reports

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY22 is not expected to be complete until September, 2023.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

Displaying 71 - 80 of 632 results
 
  • Record 1 TO 632

  1. Bridge Amplification for Blood Banking Tests

    SBC: CBR LABORATORIES, INC.            Topic: N/A

    The long term objective of this project is to develop a novel diagnostic testing methodology that csafety and volume of the blood supply. The basis for this method is an innovative amplification techBRIDGE allows for the simultaneous detection of a plurality of organisms or cellular antigens in a ssimplicity and sensitivity of BRIDGE will allow more extensive screening while reducing the overall(c ...

    SBIR Phase I 1995 Department of Health and Human Services

  2. BRIEF PSYCHOTHERAPY TRAINING IN MANAGED CARE PROGRAMS

    SBC: Inflexxion, Inc.            Topic: N/A

    HEALTH CARE COSTS ARE RISING AT EVER INCREASING RATES. MANAGED HEALTH CARE HAS EMERGED AS ONE POSSIBLE WAY OF ADDRESSING THIS ISSUE. ALREADY, THERE ARE NEARLY 60 MILLIONPEOPLE IN THE UNITED STATES WHO RECEIVED THEIR CARE THROUGH PROGRAMS SUCH AS HEALTH MAINTENANCE ORGANIZATIONS (HMOS) ANDPREFERRED PROVIDER ORGANIZATIONS (PPOS). THESE MANAGED CARESYSTEMS ALMOST ALWAYS OFFER OUTPATIENT MENTAL HEALTH ...

    SBIR Phase I 1991 Department of Health and Human Services

  3. Buprenorphine For Transdermal Analgesia

    SBC: BIOTEK, INC.            Topic: N/A

    We will demonstrate the practical feasibility of transdermal analgesic therapy based onbuprenorphine, a potent opioid already used intravenously and intramuscularly for the relief of moderateto severe pain. Preliminary in vitro experiments have confirmed that buprenorphine can pass throughhuman skin at potentially therapeutic rates. Using BIOTEK's patented DermaPatch transdermal systemit should be ...

    SBIR Phase I 1994 Department of Health and Human Services

  4. Carbon 13 Lipids, Oral Absorption in Cystic Fibrosis

    SBC: Biomolecular Products, Inc.            Topic: N/A

    Cystic fibrosis (CF) is a lethal disease with a median survival age of 29 years in 1991. Increasedsurvival is associated with a more normal growth curve. However, growth failure continues to be aproblem; for example, approximately 40% of the CF individuals in 1990 were below the 5th percentilefor normal weight and height. The nutritional deficit in CF is associated with pancreatic insufficiencyand ...

    SBIR Phase I 1994 Department of Health and Human Services

  5. CATALYTIC ANTIBODIES FOR THE TREATMENT OF AIDS

    SBC: BOSTON BIOTECHNOLOGY CORPORATION            Topic: N/A

    N/A

    SBIR Phase I 1996 Department of Health and Human Services

  6. Catheter for Simultaneous Mapping and Laser Ablation

    SBC: RARE EARTH MEDICAL, INC.            Topic: N/A

    N/A

    SBIR Phase I 1995 Department of Health and Human Services

  7. Cati Software Tool for Survey Research

    SBC: New England Research Institutes, Inc.            Topic: N/A

    N/A

    SBIR Phase I 1995 Department of Health and Human Services

  8. CAUSAL ANALYSIS OF AES--PATTERN RECOGNITION SOFTWARE

    SBC: Good Clinical Practices            Topic: N/A

    N/A

    SBIR Phase I 1997 Department of Health and Human Services

  9. C DIFFICILE ARU AS A CARRIER PROTEIN IN VACCINES

    SBC: TECHLAB, INC.            Topic: N/A

    N/A

    SBIR Phase I 1997 Department of Health and Human Services

  10. CD ROM BASED CANCER PREVENTION PROGRAM FOR THE WORKSITE

    SBC: ISA ASSOCIATES INC            Topic: N/A

    N/A

    SBIR Phase I 1997 Department of Health and Human Services
US Flag An Official Website of the United States Government